155 related articles for article (PubMed ID: 33446147)
1. Evaluation of
Weber M; Jentzen W; Hofferber R; Herrmann K; Fendler WP; Rischpler C; Umutlu L; Conti M; Costa PF; Sraieb M; Kersting D
BMC Cancer; 2021 Jan; 21(1):62. PubMed ID: 33446147
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of [
Weber M; Jentzen W; Hofferber R; Herrmann K; Fendler WP; Conti M; Wetter A; Kersting D; Rischpler C; Fragoso Costa P
EJNMMI Res; 2021 Feb; 11(1):21. PubMed ID: 33641046
[TBL] [Abstract][Full Text] [Related]
3. Image Quality and Activity Optimization in Oncologic
van Sluis J; Boellaard R; Dierckx RAJO; Stormezand GN; Glaudemans AWJM; Noordzij W
J Nucl Med; 2020 May; 61(5):764-771. PubMed ID: 31628214
[TBL] [Abstract][Full Text] [Related]
4. Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital system.
Fragoso Costa P; Jentzen W; Brahmer A; Mavroeidi IA; Zarrad F; Umutlu L; Fendler WP; Rischpler C; Herrmann K; Conti M; Seifert R; Sraieb M; Weber M; Kersting D
BMC Cancer; 2022 Aug; 22(1):899. PubMed ID: 35978274
[TBL] [Abstract][Full Text] [Related]
5. Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision: a phantom study.
Fragoso Costa P; Jentzen W; SÜßELBECK F; Fendler WP; Rischpler C; Herrmann K; Conti M; Kersting D; Weber M
Q J Nucl Med Mol Imaging; 2023 Mar; 67(1):57-68. PubMed ID: 34309334
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. The value of Bayesian penalized likelihood reconstruction for improving lesion conspicuity of malignant lung tumors on
Kurita Y; Ichikawa Y; Nakanishi T; Tomita Y; Hasegawa D; Murashima S; Hirano T; Sakuma H
Ann Nucl Med; 2020 Apr; 34(4):272-279. PubMed ID: 32060780
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of
Hotta M; Minamimoto R; Yano H; Gohda Y; Shuno Y
Cancer Imaging; 2018 Jan; 18(1):4. PubMed ID: 29378659
[TBL] [Abstract][Full Text] [Related]
9. Simulated Reduced-Count Whole-Body FDG PET: Evaluation in Children and Young Adults Imaged on a Digital PET Scanner.
Alves VPV; Brady S; Ata NA; Li Y; MacLean J; Zhang B; Sharp SE; Trout AT
AJR Am J Roentgenol; 2022 Dec; 219(6):952-961. PubMed ID: 35731102
[No Abstract] [Full Text] [Related]
10. Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CT.
Alberts I; Hünermund JN; Prenosil G; Mingels C; Bohn KP; Viscione M; Sari H; Vollnberg B; Shi K; Afshar-Oromieh A; Rominger A
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2395-2404. PubMed ID: 33797596
[TBL] [Abstract][Full Text] [Related]
11. Head-to-head intra-individual comparison of total-body 2-[
Chen X; Hu P; Yu H; Tan H; He Y; Cao S; Zhou Y; Shi H
Eur Radiol; 2023 Nov; 33(11):7890-7898. PubMed ID: 37338551
[TBL] [Abstract][Full Text] [Related]
12.
Sibille L; Seifert R; Avramovic N; Vehren T; Spottiswoode B; Zuehlsdorff S; Schäfers M
Radiology; 2020 Feb; 294(2):445-452. PubMed ID: 31821122
[TBL] [Abstract][Full Text] [Related]
13. Radiomics based on
Ou X; Zhang J; Wang J; Pang F; Wang Y; Wei X; Ma X
Cancer Med; 2020 Jan; 9(2):496-506. PubMed ID: 31769230
[TBL] [Abstract][Full Text] [Related]
14. Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [
Alberts I; Sachpekidis C; Prenosil G; Viscione M; Bohn KP; Mingels C; Shi K; Ashar-Oromieh A; Rominger A
Ann Nucl Med; 2021 Apr; 35(4):485-492. PubMed ID: 33550515
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Penalized-Likelihood Estimation Reconstruction on a Digital Time-of-Flight PET/CT Scanner for
Lindström E; Sundin A; Trampal C; Lindsjö L; Ilan E; Danfors T; Antoni G; Sörensen J; Lubberink M
J Nucl Med; 2018 Jul; 59(7):1152-1158. PubMed ID: 29449445
[TBL] [Abstract][Full Text] [Related]
16. The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.
Liu Y
Nucl Med Commun; 2017 Apr; 38(4):319-324. PubMed ID: 28225435
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and Clinical Impact of Staging
Albano D; Ferro P; Bosio G; Fallanca F; Re A; Tucci A; Maria Ferreri AJ; Angelillo P; Gianolli L; Giubbini R; Bertagna F
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):e457-e464. PubMed ID: 31129112
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of MLACF based calculated attenuation brain PET imaging for FDG patient studies.
Bal H; Panin VY; Platsch G; Defrise M; Hayden C; Hutton C; Serrano B; Paulmier B; Casey ME
Phys Med Biol; 2017 Apr; 62(7):2542-2558. PubMed ID: 28165328
[TBL] [Abstract][Full Text] [Related]
19. Image Quality and Semiquantitative Measurements on the Biograph Vision PET/CT System: Initial Experiences and Comparison with the Biograph mCT.
van Sluis J; Boellaard R; Somasundaram A; van Snick PH; Borra RJH; Dierckx RAJO; Stormezand GN; Glaudemans AWJM; Noordzij W
J Nucl Med; 2020 Jan; 61(1):129-135. PubMed ID: 31253742
[TBL] [Abstract][Full Text] [Related]
20. Comparison of
Kaste SC; Snyder SE; Metzger ML; Sandlund JT; Howard SC; Krasin M; Shulkin BL
J Nucl Med; 2017 Mar; 58(3):419-424. PubMed ID: 27609791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]